Filter Results:
(1,048)
Show Results For
- All HBS Web
(1,938)
- People (3)
- News (580)
- Research (1,048)
- Events (3)
- Multimedia (19)
- Faculty Publications (563)
Show Results For
- All HBS Web
(1,938)
- People (3)
- News (580)
- Research (1,048)
- Events (3)
- Multimedia (19)
- Faculty Publications (563)
Sort by
- August 2019
- Case
Volkswagen and Suzuki (A): A Match Made in Heaven?
By: Ranjay Gulati and Saloni Chaturvedi
The alliance between Volkswagen and Suzuki in 2009 was expected to help Volkswagen become the world’s largest carmaker and Suzuki gain expertise in fuel-efficient technologies. In addition, each promised to help the other in the two largest emerging markets. While... View Details
Gulati, Ranjay, and Saloni Chaturvedi. "Volkswagen and Suzuki (A): A Match Made in Heaven?" Harvard Business School Case 420-037, August 2019.
- March 2022
- Supplement
Pakistan Rising: Bazaar's Growth Story (B)
By: Paul A. Gompers and Gamze Yucaoglu
The case opens in January 2022 as Hamza Jawaid and Saad Jangda, co-founders of Bazaar technologies (Bazaar), the Pakistani high growth B2B e-commerce marketplace, are looking over the performance of the newly launched “buy now, play later” feature. The traction looks... View Details
Keywords: B2B; Business Model; Emerging Markets; For-Profit Firms; Strategy; Digital Platforms; Information Technology; Value Creation; Globalization; Competition; Expansion; Profit; Resource Allocation; Diversification; Corporate Strategy; Pakistan
Gompers, Paul A., and Gamze Yucaoglu. "Pakistan Rising: Bazaar's Growth Story (B)." Harvard Business School Supplement 822-099, March 2022.
- September 2014
- Article
Defining the Value of Proton Therapy Using Time-Driven Activity-Based Costing
By: N.G. Thaker, A.B. Guzman, Thomas W. Feeley, T.M. Jones, J.R. Incalcaterra, C. Kolom, S.J. Frank, L.S. Tatum, Ronald S. Walters, Scott B. Cantor, D.I. Rosenthal, A.S. Garden, G.B. Gunn, C.D. Fuller and M.B. Palmer
Technological innovations in radiation therapy (RT) have rapidly improved the quality of care for patients with head and neck cancer. Intensity-modulated proton therapy (MPT) holds promise of further improving outcomes compared with the current photon-based technique... View Details
Keywords: Time-Driven Activity-Based Costing; Health Care and Treatment; Technological Innovation; Activity Based Costing and Management
Thaker, N.G., A.B. Guzman, Thomas W. Feeley, T.M. Jones, J.R. Incalcaterra, C. Kolom, S.J. Frank, L.S. Tatum, Ronald S. Walters, Scott B. Cantor, D.I. Rosenthal, A.S. Garden, G.B. Gunn, C.D. Fuller, and M.B. Palmer. "Defining the Value of Proton Therapy Using Time-Driven Activity-Based Costing." Oncology Payers, no. 1 (September 2014): 22–28.
- 2011
- Chapter
Health Care Applications: From Hospitals to Physicians, from Productive Efficiency to Quality Frontiers
By: Jon Chilingerian and H. David Sherman
This chapter focuses on health-care applications of DEA. The paper begins with a brief history of health applications and discusses some of the models and the motivation behind the applications. Using DEA to develop quality frontiers in health services is offered as a... View Details
Keywords: Data Envelopment Analysis; Physicians; Hospitals; HMOs; Frontier Analysis; Efficiency; Health Care and Treatment; Performance; Quality
Chilingerian, Jon, and H. David Sherman. "Health Care Applications: From Hospitals to Physicians, from Productive Efficiency to Quality Frontiers." Chap. 16 in Handbook on Data Envelopment Analysis. 2nd edition Vol. 164, edited by William W. Cooper, Lawrence M. Seiford, and Joe Zhu, 445–493. International Series in Operations Research & Management Science. New York, NY: Springer, 2011.
- December 2021 (Revised January 2023)
- Case
Katerra (A)
By: Lindsay N. Hyde, Thomas R. Eisenmann and Tom Quinn
In April 2020, Katerra executives struggled with a series of decisions that would determine the fate of one of the best-funded construction startups in history. Katerra was founded in 2015 by technology-industry executive Michael Marks and commercial real estate... View Details
Keywords: Business Startups; Insolvency and Bankruptcy; Entrepreneurship; Failure; Construction; Real Estate Industry; Technology Industry; United States
Hyde, Lindsay N., Thomas R. Eisenmann, and Tom Quinn. "Katerra (A)." Harvard Business School Case 822-021, December 2021. (Revised January 2023.)
- June 2004 (Revised November 2004)
- Case
Acorda Therapeutics: Rebuilding the Spinal Cord
Acorda is an early-stage life science start-up with a promising product that is close to reaching the market (Phase III clinical trials). The company is grappling with how to expand its portfolio of molecules to make the business more sustainable. It faces classic... View Details
Keywords: Decision Making; Science-Based Business; Health Testing and Trials; Business Startups; Product Development; Biotechnology Industry
Enriquez-Cabot, Juan, Jonathan West, Marina Kolesnik, and Fiona Murray. "Acorda Therapeutics: Rebuilding the Spinal Cord." Harvard Business School Case 604-014, June 2004. (Revised November 2004.)
- September 1995
- Case
Apollo Hospitals of India (B)
The Indian Hospitals Corp. (IHC), a branch of Apollo Hospitals Group, is considering building a hospital and primary-care medical center in Colombo, the capital of Sri-Lanka, a small island off the southern coast of India. This case describes economic, social, and... View Details
Loveman, Gary W., and Jamie O'Connell. "Apollo Hospitals of India (B)." Harvard Business School Case 396-028, September 1995.
- June 2005
- Case
Furqan Nazeeri and the IMTrader Spin-Out
By: Lynda M. Applegate and Brian DeLacey
Furqan Nazeeri is looking to spin out a promising set of products and technologies from an established financial services firm. Designed as an exercise in negotiation. Includes material from the original business plan, and it is possible to simulate a negotiation... View Details
Keywords: Business Startups; Business or Company Management; Negotiation Process; Product Development; Technology Adoption
Applegate, Lynda M., and Brian DeLacey. "Furqan Nazeeri and the IMTrader Spin-Out." Harvard Business School Case 805-147, June 2005.
- 2014
- Working Paper
The Decoupling Effect of Digital Disruptors
By: Thales S. Teixeira and Peter Jamieson
While the Internet's first wave of disruption was marked by the unbundling of digital content, the second wave, decoupling, promises to generate more casualties in an even broader array of industries. Digital start-ups are disrupting traditional businesses by inserting... View Details
Teixeira, Thales S., and Peter Jamieson. "The Decoupling Effect of Digital Disruptors." Harvard Business School Working Paper, No. 15-031, October 2014.
- April 2015
- Case
Accor: Designing an Asset-Right Business and Disclosure Strategy
By: Mozaffar Khan and George Serafeim
Sebastien Bazin was now in charge of Accor, the world's largest French hotelier, a CAC 40 company with 3,600 hotels in 92 countries and a market cap of €10 billion. Previously as the European head of Colony Capital, one of the largest private equity groups and the... View Details
Khan, Mozaffar, and George Serafeim. "Accor: Designing an Asset-Right Business and Disclosure Strategy." Harvard Business School Case 115-036, April 2015.
- June 9, 2023
- Article
A Radical Treatment for Insulin Pricing
By: Leemore S. Dafny
In 2021, the Food and Drug Administration (FDA) approved the first interchangeable biosimilar for long-acting insulin, which many hoped would be substantially cheaper than the reference branded product. I explain why prices have barely changed, and argue that a... View Details
Keywords: Biosimilars; Rebates; Pharmaceuticals; Health Care and Treatment; Price; Governing Rules, Regulations, and Reforms; Pharmaceutical Industry; United States
Dafny, Leemore S. "A Radical Treatment for Insulin Pricing." New England Journal of Medicine 386, no. 23 (June 9, 2023): 2157–2159.
- Research Summary
Seeing Thought
By: Gerald Zaltman
This program of research combines the results from ZMET studies to create marketing stimuli such as advertising, retail store designs, product concepts, product design, and so forth, which are then presented to a sample of consumers whose reactions are observed using... View Details
- March 2024
- Article
The Political Effects of Immigration: Culture or Economics?
By: Alberto Alesina and Marco Tabellini
We review the growing literature on the political economy of immigration. First, we discuss the effects of immigration on a wide range of political and social outcomes. The existing evidence suggests that immigrants often, but not always, trigger backlash, increasing... View Details
Keywords: Political Backlash; Cultural Beliefs; Immigration; Political Elections; Outcome or Result; Social Issues; Perception
Alesina, Alberto, and Marco Tabellini. "The Political Effects of Immigration: Culture or Economics?" Journal of Economic Literature 62, no. 1 (March 2024): 5–46.
- March 2012
- Case
Schuberg Philis
By: Thomas J. DeLong and Daniela Beyersdorfer
The Dutch professional service firm Schuberg Philis has within a few years grown into a well-known player in the Dutch IT outsourcing market and regularly wins high customer- satisfaction marks. The growing workload and 100% promise to customers have increased the... View Details
Keywords: Growth Management; Organizational Culture; Management Style; Alignment; Information Technology Industry; Netherlands
DeLong, Thomas J., and Daniela Beyersdorfer. "Schuberg Philis." Harvard Business School Case 412-092, March 2012.
- May 1998 (Revised February 1999)
- Case
Diamond in the Rough (A)
By: Thomas J. DeLong and Catherine M. Conneely
Diamond Technology Partners, a consulting firm based in Chicago, was founded in 1994 by Mel Bergstein and Chris Moffitt, with investment from founding partners and Safeguard Scientifics. In April 1996, just after fiscal year-end, the two largest clients withdrew from... View Details
Keywords: Information Technology; Entrepreneurship; Going Public; Crisis Management; Finance; Consulting Industry; Chicago
DeLong, Thomas J., and Catherine M. Conneely. "Diamond in the Rough (A)." Harvard Business School Case 898-115, May 1998. (Revised February 1999.)
- January 2014
- Case
Delhi-Mumbai Industrial Corridor: India's Road to Prosperity?
By: John Macomber and Vidhya Muthuram
The Delhi-Mumbai Industrial Corridor (DMIC) was an ambitious $90 billion infrastructure project covering the 1483-km distance between Delhi and Mumbai. The project would create new industrial townships, high speed freight lines, six-lane expressways, airports, ports... View Details
Macomber, John, and Vidhya Muthuram. "Delhi-Mumbai Industrial Corridor: India's Road to Prosperity?" Harvard Business School Case 214-077, January 2014.
- June 2014
- Teaching Note
Andreessen Horowitz
By: Thomas Eisenmann
Andreessen Horowitz (a16z), a venture capital firm launched in 2009, has quickly broken into the VC industry's top ranks, in terms of its ability to invest in Silicon Valley's most promising startups. The case recounts the firm's history; describes its co-founders'... View Details
- August 2009 (Revised August 2010)
- Case
Calera Corporation
By: Joseph B. Lassiter III, Thomas J. Steenburgh and Lauren Barley
Brent Constantz, founder, CEO, and president of Calera Corporation, felt a surge of optimism as he gazed at the recently commissioned prototype flue gas processing line at Calera's R&D facility in Moss Landing, California. It was late May 2009, and Calera was an... View Details
Keywords: Business Startups; Entrepreneurship; Product Design; Product Development; Environmental Sustainability; Commercialization; Green Technology Industry
Lassiter, Joseph B., III, Thomas J. Steenburgh, and Lauren Barley. "Calera Corporation." Harvard Business School Case 810-030, August 2009. (Revised August 2010.)
- November 2018
- Case
David Hysong and SHEPHERD Therapeutics
By: Ananth Raman, John Masko and Aldo Sesia
In 2016, David Hysong, at age 27, found out he had a rare, incurable cancer. Rather than wait around to die, Hysong, a recent graduate of Harvard Divinity School, decided to launch a biotechnology company called Shepherd Therapeutics to development treatments for his... View Details
- 07 Nov 2007
- Op-Ed
How Marketing Hype Hurt Boeing and Apple
and brand-building can boost stock prices by raising customer and investor expectations. But the penalties for not delivering on marketing promises are fast becoming as significant as not meeting quarterly earnings targets. Boeing had... View Details